Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
K
Kazia Therapeutics Ltd
F:NV9
Kazia Therapeutics Ltd
F:NV9
Price:
0.7
EUR
Market Closed
Market Cap:
€104.7m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently viewed
Price
Wall St Price Targets
NV9 Price Forecast
Based on 9 analysts
Based on 9 analysts
+296% Upside
from
€0.7
today
Kazia Therapeutics Ltd (NV9)’s 12-month stock price forecast through December 2022 has a consensus target of €2.77, implying 296% upside. The forecast is based on price targets from 9 Wall Street analysts.
Kazia Therapeutics Ltd Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is NV9's stock price target?
Price Target
2.77
EUR
2.77
EUR
According to Wall Street analysts, the average 1-year price target for NV9 is 2.77 EUR with a low forecast of 1.73 EUR and a high forecast of 4.23 EUR.
What is the Revenue forecast for Kazia Therapeutics Ltd?
Projected CAGR
189%
189%
Over the last 13 years, the compound annual growth rate for Revenue has been -18%. The projected CAGR for the next 8 years is 189%.